These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6436549)

  • 1. [Toxicological studies on a new cephamycin, MT-141. VII. Its locally-irritating activity in rabbits].
    Kurebe M; Kawaoto H; Sasaki H; Izawa M; Asaoka H
    Jpn J Antibiot; 1984 Jun; 37(6):1163-75. PubMed ID: 6436549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxicological studies of a new cephamycin, MT-141. II. Its subacute toxicity in rats].
    Kurebe M; Yokota M; Yuda Y; Sasaki H; Niizato T; Watanabe H; Hayasaka H
    Jpn J Antibiot; 1984 May; 37(5):855-89. PubMed ID: 6434761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicological studies on a new cephamycin, MT-141, IV. Its acute toxicity in beagle dogs].
    Kurebe M; Yokota M; Kawaoto H; Niizato T; Hayasaka H; Seki M
    Jpn J Antibiot; 1984 Jun; 37(6):1070-99. PubMed ID: 6436546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscle irritation study on T-1982].
    Nakada H; Takimoto Y; Kawamura Y; Takai A
    Jpn J Antibiot; 1982 Sep; 35(9):2155-8. PubMed ID: 7143715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of clinical application of cefmetazole in perinatal period (author's transl)].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1981 Jun; 34(6):915-24. PubMed ID: 6945452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicological studies on a new cephamycin, MT-141 IX. Its teratogenicity test in rats and rabbits].
    Kurebe M; Asaoka H; Moriguchi M; Hata T; Izawa M; Nagai S
    Jpn J Antibiot; 1984 Jun; 37(6):1186-210. PubMed ID: 6436551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicological studies on a new cephamycin, MT-141. VI. Its chronic toxicity in beagle dogs].
    Kurebe M; Yokota M; Sasaki H; Niizato T; Kawaoto H; Suzuki H; Kumagai K; Seki M
    Jpn J Antibiot; 1984 Jun; 37(6):1137-62. PubMed ID: 6436548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxicological studies of a new cephamycin, MT-141. III. Its chronic toxicity in rats].
    Kurebe M; Yokota M; Kawaoto H; Niizato T; Watanabe H; Hayasaka H
    Jpn J Antibiot; 1984 May; 37(5):890-917. PubMed ID: 6434762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxicological studies on a new cephamycin, MT-141. VIII. Its fertility test in rats].
    Kurebe M; Asaoka H; Hata T; Watanabe T; Hirota C
    Jpn J Antibiot; 1984 Jun; 37(6):1176-85. PubMed ID: 6436550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicological studies on a new cephamycin, MT-141. V. Its subacute toxicity in beagle dogs].
    Kurebe M; Sasaki H; Yokota M; Watanabe H; Suzuki H; Sakamoto K; Hayasaka H
    Jpn J Antibiot; 1984 Jun; 37(6):1100-36. PubMed ID: 6436547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of safety of cefmetazole (CS-1170) in pregnant women during the perinatal stage (author's transl)].
    Jpn J Antibiot; 1981 Jun; 34(6):907-14. PubMed ID: 6945451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local irritation study with isepamicin].
    Kohira T; Yano J; Kobayashi Y; Yamamoto H
    Jpn J Antibiot; 1986 Dec; 39(12):3353-68. PubMed ID: 3560444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].
    Kawashima M; Tamura H; Kitahara Y; Jinyama K
    Jpn J Antibiot; 1982 Mar; 35(3):835-9. PubMed ID: 6954290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activity of MT-141 against anaerobic bacteria].
    Watanabe T; Hara T; Kasai T; Ishii T; Miyauchi K; Date H; Jinzaki M; Shindo H; Matsugami A; Goi H
    Jpn J Antibiot; 1984 Jun; 37(6):1058-69. PubMed ID: 6092738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind comparison of cefotetan and cefmetazole in complex urinary tract infections].
    Kamidono S; Ishigami J; Arakawa S; Umezu K; Ohmori H; Ishito N; Nihira H; Ishino T; Kurokawa K; Fujimura N
    Jpn J Antibiot; 1983 Jun; 36(6):1325-53. PubMed ID: 6361310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An experimental production of suppurative otitis media in dog, and a trial to evaluate the therapeutic effect of cefmetazole on this otitis media].
    Imori T; Matsuda H; Tohjo M; Kamata Y
    Jpn J Antibiot; 1982 Sep; 35(9):2277-87. PubMed ID: 6958884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on cefmetazole in the neonatal period (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K
    Jpn J Antibiot; 1981 Jun; 34(6):881-92. PubMed ID: 6945448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological studies on new cephamycin, MT-141. (1) Its effect on central nervous system, respiration and cardiovascular system].
    Kurebe M; Asaoka H; Yamaki Y; Sugiyama S; Shibasaki Y; Nishimori T; Kobayashi F
    Jpn J Antibiot; 1984 Jul; 37(7):1428-39. PubMed ID: 6436555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with cefmetazole in the urological fields].
    Tajima A; Ohmi Y; Masuda H; Ushiyama T; Fujii K; Hata M; Ohta N; Suzuki K; Fujita K; Aso Y
    Jpn J Antibiot; 1982 Aug; 35(8):1961-6. PubMed ID: 6961241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.